-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A recent clinical study showed that the ViroStop antiviral spray from Herb-Pharma in Switzerland can effectively reduce the impact of new coronary pneumonia on patients with mild to moderate symptoms
.
The main benefit is that the virus shedding is reduced by 60% after using the therapeutic drug, and the severity of respiratory clinical symptoms is reduced
.
This study supports the results of early in vitro tests that polyphenol mixtures can inhibit the growth of viruses in cell culture
The study included 170 SARS-CoV-2 patients diagnosed by PCR at the General Medical Clinic in Budapest, Hungary from January 15 to May 31, 2021
.
These volunteers all had mild to moderate respiratory symptoms.
Of the 170 volunteers, 86 received a nasopharyngeal spray, the patented ViroStop solution, which contains Cistus and other mixtures rich in polyphenols
.
When polyphenols attach to viral proteins, they mechanically inhibit the work of the protein, thereby preventing the virus from entering the cell
At the end of the study, the level of virus shedding was detected by PCR testing
.
The results showed that on day 12, compared with the control group, those patients who started using ViroStop spray from the first day after the test was positive had a nearly 60% reduction in virus shedding
Compared with the control group, gastrointestinal symptoms were also reduced
.
Recent studies have shown that a key factor in the spread of the virus is its ability to multiply in the gastrointestinal tract at the same time
The team's István Dr.
Jankovics commented: "The main treatment for the new crown pneumonia, of course, vaccination, but this study implies the use of ViroStop sprays can significantly inhibit the upper respiratory tract of SARS CoV 2-load, thereby to infection provider The opportunity to generate a specific immune response
.
"Infection immunity
ViroStop is an over-the-counter treatment medicine made from natural ingredients and can be used safely by children as young as three years old
.
In addition, during the course of the study, there were at least three virus variants in Hungary, so it is reasonable to assume that the polyphenol solution and the effect can effectively fight all known mutations of new coronary pneumonia
Children leave a message here